Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Esketamine and lidocaine for opioid-sparing analgesia in elderly colorectal cancer surgery
ChiCTR2300078997Phase 4Not yet recruiting
- Sponsor
- Xiangyang Central Hospital
- Start
- Dec 2023
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4 trial of esketamine and lidocaine in postoperative pain (4 arms), sponsored by Xiangyang Central Hospital. Primary endpoints: VAS pain score and Ramsay sedation score. Planned start Dec 2023; status: not yet recruiting.
02
Drugs
esketaminelidocaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on ChiCTR2300078997.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300078997.